Five-month-old Baby Ginny has officially become Singapore’s youngest high-net-worth individual after receiving a $2.4 million injection that costs more than your entire family’s collective net worth.

The life-saving dose of Zolgensma, priced at a terrifying $80,000 per milliliter, has effectively turned the infant into a walking sovereign wealth fund with better funding than most local tech startups.

While most babies are busy shitting themselves for free, Ginny is now under immense pressure to justify the $2.4 million "Series A" investment provided by 35,000 kaypoh donors.

“I donated ten dollars, so I expect a seat on the board of directors for her future career choices,” said one donor who already feels he owns a 0.000004% stake in the child’s future CPF contributions.

The medical procedure was a success, though observers noted that Ginny is now the only person in Singapore who can technically claim her urine is worth more than a Chanel handbag.

Local HR experts warn that the infant is already overqualified for most entry-level jobs in the country, as her current valuation exceeds the lifetime earnings of a mid-level civil servant.

Her parents expressed their gratitude on Instagram, while the rest of Singapore silently calculated how many Olympic gold medals she needs to win to break even for the public.

At press time, the Ministry of Education was reportedly preparing a specialized "Gold Class" syllabus for the baby to ensure she doesn't waste her million-dollar genes on a useless arts degree.